Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013


Life Science R&D Big Data Leaders Forum

03 Dec 2013 - 05 Dec 2013 - Ramada Plaza Basel, Switzerland



Bookmark and Share


This 3 day forum is the “must attend” event for those senior decision-makers looking to make the shift towards big data and for those looking to improve their implementation of data-driven approaches for their specific departments.

The first day will feature several keynote presentations from C-Level thought leaders on big data in the R&D space and heads of major research institutions who are at the front-end of the big data challenge. They will be discussing the strategic drivers for big data and key implementation guidance on how to make best use of this approach.

Day 2&3 of the Forum will feature 3 specific streams depending on the phase of R&D that is most crucial for you:

-              Discovery & Translational Big Data Forum;

-              Clinical Data Management Forum;

-              Real-World & Health Outcomes Big Data Forum.

Discovery & Translational Big Data Forum will be focusing on important issues related to use of big data to support various functions within the drug discovery process, including better designing NMEs, re-engineering and re-initiating previously failed drug programs and will enable participants to make the most informed decisions possible on how to enhance the management and application of their discovery and translational data. Clinical Data Management Forum will explore a number of areas vital to the development of clinical data management (CDM) and present key issues in selecting and implementing a CDM system. Real-World & Health Outcomes Big Data Forum will discover how to best design observational studies to get most of the real world data generated, what are the new and innovative approaches to capture, store and manage as well as what is the role of evidence and health outcomes data in decision-making.

To request the full agenda please follow the link:

http://bigdata2013.nextlevelpharma.com/request-agenda

Erika Vavrovicova

Life science Big Data Leaders Forum

Tel: +421 232 660 382

Fax: +421 2 3301 0331
Email: erika@nextlevellifesciences.com

Visit: bigdata2013.nextlevelpharma.com



Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!